HK1036280A1 - Antivirals. - Google Patents
Antivirals.Info
- Publication number
- HK1036280A1 HK1036280A1 HK01107142A HK01107142A HK1036280A1 HK 1036280 A1 HK1036280 A1 HK 1036280A1 HK 01107142 A HK01107142 A HK 01107142A HK 01107142 A HK01107142 A HK 01107142A HK 1036280 A1 HK1036280 A1 HK 1036280A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- antivirals
- Prior art date
Links
- 239000003443 antiviral agent Substances 0.000 title 1
- 229940121357 antivirals Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
- C07D213/85—Nitriles in position 3
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9800113A SE9800113D0 (sv) | 1998-01-16 | 1998-01-16 | Antivirals II |
SE9800116A SE9800116D0 (sv) | 1998-01-16 | 1998-01-16 | Antivirals I |
PCT/SE1999/000053 WO1999036406A1 (en) | 1998-01-16 | 1999-01-15 | Antivirals |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1036280A1 true HK1036280A1 (en) | 2001-12-28 |
Family
ID=26663191
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK01107142A HK1036280A1 (en) | 1998-01-16 | 2001-10-11 | Antivirals. |
Country Status (26)
Country | Link |
---|---|
US (2) | US6486183B1 (ja) |
EP (1) | EP1054867B1 (ja) |
JP (1) | JP4488621B2 (ja) |
KR (1) | KR100566445B1 (ja) |
CN (2) | CN1158261C (ja) |
AR (1) | AR016169A1 (ja) |
AT (1) | ATE264305T1 (ja) |
AU (1) | AU739766B2 (ja) |
BR (1) | BR9906933A (ja) |
CA (1) | CA2318694C (ja) |
CZ (1) | CZ299387B6 (ja) |
DE (1) | DE69916425T2 (ja) |
DK (1) | DK1054867T3 (ja) |
EA (1) | EA003327B1 (ja) |
ES (1) | ES2220039T3 (ja) |
HK (1) | HK1036280A1 (ja) |
HU (1) | HU228886B1 (ja) |
IL (1) | IL137196A0 (ja) |
MY (1) | MY129292A (ja) |
NZ (1) | NZ505543A (ja) |
PL (1) | PL191832B1 (ja) |
PT (1) | PT1054867E (ja) |
SK (1) | SK285779B6 (ja) |
TR (1) | TR200002058T2 (ja) |
TW (1) | TW470645B (ja) |
WO (1) | WO1999036406A1 (ja) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4488621B2 (ja) * | 1998-01-16 | 2010-06-23 | メディヴィル・アクチボラグ | 抗ウイルス剤 |
WO1999051613A1 (en) * | 1998-04-03 | 1999-10-14 | Medivir Ab | Prodrugs of phosphorous-containing pharmaceuticals |
SE0100733D0 (sv) | 2001-03-05 | 2001-03-05 | Medivir Ab | Non-nucleoside reverse transcriptase inhibitors |
SE0102867D0 (sv) * | 2001-08-28 | 2001-08-28 | Medivir Ab | Non-nucleoside reverse transcriptase inhibitors |
NZ548367A (en) * | 2004-01-08 | 2010-06-25 | Medivir Ab | Non-nucleoside reverse transcriptase inhibitors |
CA2620853A1 (en) * | 2005-08-31 | 2007-03-08 | Cipla Limited | Pharmaceutical combinations containing lamivudine, stavudine and nevirapine |
US7302330B1 (en) * | 2006-09-01 | 2007-11-27 | Gm Global Technology Operations, Inc. | Torque converter clutch dynamic control |
GB0623258D0 (en) | 2006-11-22 | 2007-01-03 | Remynd Nv | Thiadiazole derivatives for the treatment of neuro-degenerative diseases |
WO2012013728A1 (en) * | 2010-07-29 | 2012-02-02 | Oryzon Genomics S.A. | Arylcyclopropylamine based demethylase inhibitors of lsd1 and their medical use |
BR112014021927A2 (pt) | 2012-03-05 | 2019-09-24 | Cipla Ltd | composição farmacêutica antirretroviral, processo para preparar uma composição farmacêutica antirretroviral, método para o tratamento ou profilaxia de doenças causadas por retrovírus, e, uso de lamivudina, festinavir e nevirapina |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU687440B2 (en) * | 1993-08-24 | 1998-02-26 | Medivir Ab | Compounds and methods for inhibition of HIV and related viruses |
US5849769A (en) * | 1994-08-24 | 1998-12-15 | Medivir Ab | N-arylalkyl-N-heteroarylurea and guandine compounds and methods of treating HIV infection |
JP4488621B2 (ja) * | 1998-01-16 | 2010-06-23 | メディヴィル・アクチボラグ | 抗ウイルス剤 |
-
1999
- 1999-01-15 JP JP2000540122A patent/JP4488621B2/ja not_active Expired - Fee Related
- 1999-01-15 CZ CZ20002604A patent/CZ299387B6/cs not_active IP Right Cessation
- 1999-01-15 KR KR1020007007830A patent/KR100566445B1/ko not_active IP Right Cessation
- 1999-01-15 HU HU0100432A patent/HU228886B1/hu not_active IP Right Cessation
- 1999-01-15 MY MYPI99000158A patent/MY129292A/en unknown
- 1999-01-15 NZ NZ505543A patent/NZ505543A/xx not_active IP Right Cessation
- 1999-01-15 CN CNB99803908XA patent/CN1158261C/zh not_active Expired - Fee Related
- 1999-01-15 TW TW088100605A patent/TW470645B/zh not_active IP Right Cessation
- 1999-01-15 AT AT99903983T patent/ATE264305T1/de active
- 1999-01-15 CN CNA03127224XA patent/CN1522698A/zh active Pending
- 1999-01-15 IL IL13719699A patent/IL137196A0/xx not_active IP Right Cessation
- 1999-01-15 WO PCT/SE1999/000053 patent/WO1999036406A1/en active IP Right Grant
- 1999-01-15 US US09/600,309 patent/US6486183B1/en not_active Expired - Fee Related
- 1999-01-15 DE DE69916425T patent/DE69916425T2/de not_active Expired - Lifetime
- 1999-01-15 ES ES99903983T patent/ES2220039T3/es not_active Expired - Lifetime
- 1999-01-15 PT PT99903983T patent/PT1054867E/pt unknown
- 1999-01-15 SK SK1033-2000A patent/SK285779B6/sk not_active IP Right Cessation
- 1999-01-15 PL PL341819A patent/PL191832B1/pl not_active IP Right Cessation
- 1999-01-15 CA CA002318694A patent/CA2318694C/en not_active Expired - Fee Related
- 1999-01-15 AR ARP990100146A patent/AR016169A1/es active IP Right Grant
- 1999-01-15 EA EA200000770A patent/EA003327B1/ru not_active IP Right Cessation
- 1999-01-15 DK DK99903983T patent/DK1054867T3/da active
- 1999-01-15 AU AU24450/99A patent/AU739766B2/en not_active Ceased
- 1999-01-15 TR TR2000/02058T patent/TR200002058T2/xx unknown
- 1999-01-15 BR BR9906933-4A patent/BR9906933A/pt not_active IP Right Cessation
- 1999-01-15 EP EP99903983A patent/EP1054867B1/en not_active Expired - Lifetime
-
2001
- 2001-10-11 HK HK01107142A patent/HK1036280A1/xx not_active IP Right Cessation
-
2002
- 2002-09-12 US US10/243,118 patent/US7148243B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA996185B (en) | Sulfanylsilanes. | |
DE69941083D1 (en) | 12,13-cyclopropan-epothilonderivate | |
ZA200005136B (en) | Dihydropyrimides. | |
EG24814A (en) | Novel compounds. | |
ZA99454B (en) | Novel dosage form. | |
ZA99254B (en) | Benzosulfone derivatives. | |
ZA200000865B (en) | Dicarboalkoxy dioxolanes. | |
ZA991272B (en) | Novel thiobenzamides. | |
MXPA00012526A (es) | Columna mejorada. | |
ZA996133B (en) | Substituted benzamides. | |
HK1038166A1 (en) | Toothbrush. | |
ZA992443B (en) | Hydroxy-methyl-hexanones. | |
ZA991550B (en) | Cyclohexanediole derivatives. | |
HK1036280A1 (en) | Antivirals. | |
ZA993123B (en) | Trisresorcinyltriazines. | |
ZA995325B (en) | Methylcyclotetradec-5-en-1-ones. | |
HK1021879A1 (en) | Carrying case. | |
ZA994441B (en) | Mill. | |
ZA993138B (en) | Press. | |
GB9810998D0 (en) | Antitumour 1,5-diazaanthraquinones | |
HK1028588A1 (en) | Case. | |
GB2344342B (en) | I.S Machine | |
ZA99292B (en) | Antivirals. | |
ZA987329B (en) | Dispensers. | |
ZA996936B (en) | Railbreak indicating arrangement. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20140115 |